Educational
program in MS:
Focus on patient monitoring and fluid biomakers
Barcelona – September 19-20 2022
Overview
2-day hybrid educational activity focused on patient monitoring and fluid biomarkers with Cemcat and International KOL in their field.
Aims
With new insights into the pathogenesis of demyelinating diseases, the development of innovative monitoring tools to improve diagnosis and a greater availability of new treatment methods in clinical practice, neurologists specializing in multiple sclerosis are compelled to stay up to date with all the latest developments and ideas about best practices.
This course comprehensively addresses some of the most important topic areas in multiple sclerosis such as patient monitoring and fluid biomarkers.
“This course is aimed at MSologists”
Methodology
The course takes place over 2 days, with 1 session per day with 6 presentations per session. Each speaker is allocated 30 minutes, including 20 minutes of presentation and 10 minutes addressed to discussion.
Each session will be recorded and the video will be uploaded onto the course platform during 1 week.
Each session will have a forum open during a week to solve any doubts from the audience.
Sessions
Day 1
Getting to know the Cemcat
Neurologist - Chair of Neurology department and Director of Multiple Sclerosis Centre of Catalonia (Cemcat). HUVH
Digital monitoring: is it already possible?
Neurologist - Cemcat. HUVH
Expert MS patient
Nurse - Cemcat. HUVH
PMS starts from onset. True or false?
Neurologist - Clinical Chief Neurology-Neuroimmunology Department - Cemcat. HUVH
How to monitor MS patients with MRI?
Neuroradiologist - Head of Neuroradiology Department - IDI. HUVH
With special emphasys to patient monitoring areas
Neurologist - Cemcat. HUVH
Day 2
Neurofilaments: Do we need MR anymore?
Senior Physician - Head Multiple Sclerosis Centre
OGB: IGG IGM and light chains
Head MS and neuroinflammation Unit, Head CSF laboratory Ulm, Germany
Other Biomarkers: GFAP, CXCL-13… and others
Head of Neurology Biomarker Research Unit, Medical University of Graz, Austria
Other Biomarkers in MS: Is there any life beyond NFL?
Neurologist - Head of Neuroimmunology Lab - Cemcat. HUVH
NFL Determination: A practical overview on SIMOA
Principal Investigator - Cemcat. VHIR
Biomarkers’ potential application in the clinical practice
Neurologist - Chair of Neurology department and Director of Multiple Sclerosis Centre of Catalonia (Cemcat). HUVH
Dr. Manuel Comabella
Neurologist - Head of Neuroimmunology Lab - Cemcat. HUVH
Register here
If you have already registered to any previous session of this program, you don't need to register again.
Thanks for subscribing to the program
Focus on patient monitoring and fluid biomakers